ELANE and chronic obstructive pulmonary disease: AZD9668, also known as Alvelestat, is a third-generation reversible inhibitor of human NE that has undergone clinical trials for pulmonary diseases, including bronchiectasis, cystic fibrosis, and chronic obstructive pulmonary disease (COPD) [75,76,77].